Cleared Traditional

K896858 - SOLCOTRANS INTRAOPERATIVE AUTOTRANSFUSION SYSTEM

K896858 is an FDA 510(k) clearance for SOLCOTRANS INTRAOPERATIVE AUTOTRANSFUSI..., manufactured by Solco Basle, Inc.. The device is a Class 2 Anesthesiology device with product code CAC cleared through the Traditional 510(k) pathway after a 121-day FDA review.

K896858 · Solco Basle, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1990
Decision
121d
Days
Class 2
Risk

K896858 is an FDA 510(k) clearance for the SOLCOTRANS INTRAOPERATIVE AUTOTRANSFUSION SYSTEM. Classified as Apparatus, Autotransfusion (product code CAC), Class II - Special Controls.

Submitted by Solco Basle, Inc. (Hingham, US). The FDA issued a Cleared decision on April 5, 1990 after a review of 121 days - within the typical 510(k) review window.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5830 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Solco Basle, Inc. devices

FDA 510(k) Submission Details - K896858

510(k) Number K896858 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 05, 1989
Decision Date April 05, 1990
Days to Decision 121 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
19d faster than avg
Panel avg: 140d · This submission: 121d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAC Device Classification - Class 2, Special Controls

Product Code CAC Apparatus, Autotransfusion
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5830
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAC Apparatus, Autotransfusion

All 168
Devices cleared under the same product code (CAC) and FDA review panel - the closest regulatory comparables to K896858.
ORTH-EVAC TM
K900325 · Deknatel, Inc. · Jul 1990
AUTOVAC(R) AUTOTRANSFUSION SYSTEM, 7900 SERIES
K901138 · Boehringer Laboratories · Jun 1990
AP900/PRP MODULE AND ACCESSORIES, MODIFICATION
K893218 · Electromedics, Inc. · Jun 1990
AUTOTRANSFUSION RESERVIOR MODEL 7900 MODIFICATION
K895297 · Boehringer Laboratories · Mar 1990
ATRIUM 2050 CHEST DRAIN BLOOD RECOVERY SYSTEM
K897126 · Atrium Medical Corp. · Mar 1990
ATRIUM 2052 CHEST DRAIN, DUAL COLLECTION BLOOD
K897127 · Atrium Medical Corp. · Mar 1990